Perrigo Company strengthens board with new independent directors
End of Quarter Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Perrigo Company ( (PRGO) ) has shared an announcement.
On June 30, 2026, Perrigo Company plc expanded its board of directors from eight to ten members and appointed seasoned consumer and retail executives Salman Amin and Omer Gajial as independent directors. Amin, a former CEO of pladis Global with prior senior roles at SC Johnson, PepsiCo and Procter & Gamble, joins the Audit and Nominating and Governance Committees, while Gajial, currently CEO of GoTo Foods and formerly a senior executive at Albertsons, will serve on the Talent and Compensation Committee, a move that strengthens Perrigo’s governance and brings additional expertise in consumer products, retail and digital transformation to support its strategic priorities.
The company noted there are no special arrangements or related-party transactions tied to these appointments, and both new directors will receive standard non-employee director compensation. By adding leaders with track records in driving growth and operational improvements, Perrigo signals an intensified focus on execution in its self-care and consumer health markets, with potential implications for strategic oversight, capital allocation and the acceleration of its ongoing transformation efforts.
The most recent analyst rating on (PRGO) stock is a Buy
with a $17.00 price target.
To see the full list of analyst forecasts on Perrigo Company stock,
see the PRGO Stock Forecast page.
Spark’s Take on PRGO Stock
According to Spark, TipRanks’ AI Analyst, PRGO is a Neutral.
The score is held down primarily by weak financial performance (large TTM losses, declining revenue, and leverage) and a still-soft technical trend. Offsets include continued (though weakening) cash generation, reaffirmed guidance with cost-savings initiatives, and income support from a very high dividend yield, but near-term execution and leadership-transition risks remain meaningful.
To see Spark’s full report on PRGO stock,
click here.
More about Perrigo Company
Perrigo Company plc is a leading pure-play self-care company focused on over-the-counter consumer health products, with more than a century of experience serving consumers primarily in North America and Europe. Its portfolio spans store-brand private label offerings and branded products such as Opill, Mederma, Compeed, EllaOne and Jungle Formula, leveraging cash-generative private labels to fund growth in its leading brands.
Average Trading Volume: 3,255,866
Technical Sentiment Signal: Sell
Current Market Cap: $1.38B
For detailed information about PRGO stock, go to TipRanks’ Stock Analysis page.
